Characterization of a novel lipoprotein expressed by Haemophilus ducreyi.

Infection and Immunity
T J HiltkeStanley M Spinola

Abstract

Pooled sera from patients with chancroid contain antibodies to a Haemophilus ducreyi antigen with an approximate molecular weight of 28,000 (28K). Rabbit polyclonal serum that reacts to a 28K protein can be used to detect H. ducreyi in clinical samples. A monoclonal antibody, designated 5C9, bound to a 28K outer membrane protein and to 35 of 35 H. ducreyi isolates with diverse geographic origins and did not bind to many species of the families Pasteurellaceae, Neisseriaceae, and Enterobacteriaceae or to Corynebacterium and Candida species strains. A 5C9-reactive phage was recovered from a genomic library, and the gene encoding the 28K protein was localized to a 626-bp open reading frame, designated hlp, for H. ducreyi lipoprotein. Translation of hlp predicted a 23K polypeptide that contained a lipoprotein processing site. Escherichia coli transformed with a plasmid containing hlp expressed a novel, membrane-associated protein that could be labeled with [3H]palmitic acid. In H. ducreyi, processing of Hlp was inhibited by globomycin. Database searches found no homologies to hlp or to the predicted Hlp amino acid sequence. Restriction enzyme analysis indicated that hlp was conserved among H. ducreyi isolates. Serum samples from pa...Continue Reading

References

Dec 1, 1977·Proceedings of the National Academy of Sciences of the United States of America·F SangerA R Coulson
Aug 1, 1992·Journal of Clinical Microbiology·M DesjardinsD W Cameron
Aug 1, 1991·The Journal of Infectious Diseases·B K PurcellE J Hansen
Feb 1, 1991·The Journal of Infectious Diseases·F A PlummerA R Ronald
Oct 5, 1990·Journal of Molecular Biology·S F AltschulD J Lipman
May 1, 1989·Molecular Microbiology·J P WoodsJ G Cannon
Jun 1, 1986·Journal of Bacteriology·A P PugsleyM Schwartz
Apr 1, 1983·Cell·W M HolmesM Rosenberg
Jul 28, 1995·Science·R D FleischmannJ M Merrick
Jul 1, 1995·Clinical Microbiology Reviews·D L Trees, S A Morse
Aug 1, 1995·Infection and Immunity·M M HobbsT H Kawula
Mar 1, 1993·Microbiological Reviews·A P Pugsley
Jun 1, 1994·The Journal of Infectious Diseases·P A TottenW E Stamm
Dec 15, 1993·Annals of Internal Medicine·E E TelzakH W Jaffe
Feb 1, 1996·Journal of Bacteriology·R J BrentjensS M Spinola

❮ Previous
Next ❯

Citations

Feb 26, 2000·Infection and Immunity·C ElkinsB Olsen
Mar 24, 2005·Infection and Immunity·Catherine Dinitra WhiteChristopher Elkins
Oct 2, 2002·Journal of Clinical Microbiology·Kristine PattersonChristopher Elkins

❮ Previous
Next ❯

Related Concepts

Related Feeds

Bacteriophage: Phage Therapy

Phage therapy uses bacterial viruses (bacteriophages) to treat bacterial infections and is widely being recognized as an alternative to antibiotics. Here is the latest research.

ApoE, Lipids & Cholesterol

Serum cholesterol, triglycerides, apolipoprotein B (APOB)-containing lipoproteins (very low-density lipoprotein (VLDL), immediate-density lipoprotein (IDL), and low-density lipoprotein (LDL), lipoprotein A (LPA)) and the total cholesterol/high-density lipoprotein (HDL) cholesterol ratio are all connected in diseases. Here is the latest research.